| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Arthur J Atkinson | |
| P2860 | cites work | A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. | Q24631193 |
| The brain interstitial system: Anatomy, modeling, in vivo measurement, and applications | Q26770216 | ||
| Progressive multifocal leukoencephalopathy: current treatment options and future perspectives | Q26776236 | ||
| The Glymphatic System: A Beginner's Guide | Q28084591 | ||
| Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate | Q28361252 | ||
| Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumours | Q28366035 | ||
| Clinical relevance of pharmacological and physiological data in intrathecal baclofen therapy. | Q30828677 | ||
| Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. | Q33502327 | ||
| Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America | Q33898624 | ||
| Practice guidelines for the management of bacterial meningitis | Q33982444 | ||
| Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis | Q33984222 | ||
| Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus | Q34116952 | ||
| Clinical pharmacokinetics of cytarabine formulations | Q34142812 | ||
| Prevalence of Antibodies in Human Sera against JC Virus, an Isolate from a Case of Progressive Multifocal Leukoencephalopathy | Q34213119 | ||
| A note from history: discovery of the cerebrospinal fluid | Q34228038 | ||
| Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology | Q34325791 | ||
| The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis | Q36222151 | ||
| Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis | Q36244643 | ||
| A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies | Q37036934 | ||
| Improving the role of intraventricular antimicrobial agents in the management of meningitis | Q37478445 | ||
| Intracerebroventricular administration of drugs | Q37532501 | ||
| Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer | Q37917105 | ||
| Anatomy and physiology of cerebrospinal fluid | Q37958469 | ||
| Intracerebroventricular opioids for intractable pain | Q37980479 | ||
| Systematic review of efficacy, pharmacokinetics, and administration of intraventricular vancomycin in adults | Q38054627 | ||
| Choroid plexus--CSF system: Recent developments and clinical correlations | Q38673593 | ||
| The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks | Q39064699 | ||
| Intracerebroventricular Delivery as a Safe, Long-Term Route of Drug Administration | Q39089589 | ||
| Treatment of gram-negative bacillary meningitis in adults | Q39896924 | ||
| Ommaya reservoir infections: a 16-year retrospective analysis. | Q40225520 | ||
| Vancomycin administration into the cerebrospinal fluid: a review | Q40842373 | ||
| The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line | Q41013438 | ||
| Complications related to the use of an intraventricular access device for the treatment of leptomeningeal metastases from solid tumor: a single centre experience in 112 patients | Q41164956 | ||
| In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy | Q41337000 | ||
| Aminoglycoside Therapy of Gram-Negative Bacillary Meningitis | Q41870546 | ||
| Instillation of vancomycin into a cerebrospinal fluid reservoir to clear infection: pharmacokinetic considerations | Q43524591 | ||
| "Concentration x time" methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms | Q43538665 | ||
| Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration | Q44483617 | ||
| Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy | Q44642100 | ||
| Severe complications after intrathecal methotrexate (MTX) for treatment of primary central nervous system lymphoma (PCNSL). | Q44787969 | ||
| Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2. | Q45115245 | ||
| Comparison of the accuracy of ventricular catheter placement using freehand placement, ultrasonic guidance, and stereotactic neuronavigation | Q45455339 | ||
| Ependymal cell differentiation and GLUT1 expression is a synchronous process in the ventricular wall. | Q46845544 | ||
| Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. | Q48164677 | ||
| Intraventricular therapy of cryptococcal meningitis via a subcutaneous reservoir | Q48325991 | ||
| GLUT-1 glucose transporter is present within apical and basolateral membranes of brain epithelial interfaces and in microvascular endothelia with and without tight junctions | Q48538894 | ||
| Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis | Q48595709 | ||
| Kinetics of blood-cerebrospinal fluid glucose transfer in the normal dog | Q49026917 | ||
| The cerebrospinal fluid glucose concentration. Steady state and kinetic studies in patient with cryptococcal meningitis | Q49086792 | ||
| Transport of methotrexate by the choroid plexus. | Q51187729 | ||
| Conservative management of patients with cerebrospinal fluid shunt infections. | Q51237332 | ||
| Subcutaneous reservoir and pump for sterile access to ventricular cerebrospinal fluid | Q51281965 | ||
| Measurement of cerebrospinal fluid output through external ventricular drainage in one hundred infants and children: correlation with cerebrospinal fluid production. | Q52047349 | ||
| Frameless, electromagnetic image-guided ventriculostomy for ventriculoperitoneal shunt and Ommaya reservoir placement. | Q53082764 | ||
| Kinetics of intraventricular vancomycin in infections of cerebrospinal fluid shunts | Q67956625 | ||
| Intraventricular vancomycin: observations of tolerance and pharmacokinetics in two infants with ventricular shunt infections | Q70007599 | ||
| Cytosine arabinoside cerebrospinal fluid kinetics | Q70945105 | ||
| Active transport of methotrexate from cerebrospinal fluid in humans | Q71235522 | ||
| Pharmacokinetics of intrathecally administered amphotericin B | Q72526541 | ||
| 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases | Q74249125 | ||
| Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma | Q74451749 | ||
| DIAGNOSTIC AND PROGNOSTIC VALUE OF CLINICAL AND LABORATORY FINDINGS IN CRYPTOCOCCAL MENINGITIS, A FOLLOW-UP STUDY OF FORTY PATIENTS | Q76564348 | ||
| The improved prognosis of cryptococcal meningitis with amphotericin B therapy | Q79672851 | ||
| Liposomal cytarabine for central nervous system embryonal tumors in children and young adults | Q85064641 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P304 | page(s) | 117-124 | |
| P577 | publication date | 2017-09-15 | |
| P1476 | title | Intracerebroventricular drug administration | |
| P478 | volume | 25 |
Search more.